Format

Send to

Choose Destination
Vaccine. 2016 Oct 26;34(45):5406-5409. doi: 10.1016/j.vaccine.2016.08.042. Epub 2016 Aug 29.

Review of prescribing information for influenza vaccines for pregnant and lactating women.

Author information

1
Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD 21205, USA. Electronic address: tproveau@jhu.edu.
2
Initiative for Vaccine Research, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland.
3
Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD 21205, USA.

Abstract

Information provided by most influenza vaccine manufacturers do not reflect the recommendations of WHO and/or national public health advisory groups with regard to the use of influenza vaccines in pregnant or lactating women. The majority of vaccines contain precautionary language which could discourage use in pregnant women and some include stronger language discouraging or contradicting use in pregnant or lactating women. Regulators and manufacturers should regularly assess the language of pregnancy and lactation sections in product information for vaccines and include information from national public health advisory groups regarding use by pregnant or lactating women and data from relevant studies.

KEYWORDS:

Influenza vaccine; Lactation; Pregnancy; Vaccine safety

PMID:
27595450
DOI:
10.1016/j.vaccine.2016.08.042
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center